These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 8651091

  • 1. Adjunctive intracoronary urokinase therapy during percutaneous transluminal coronary angioplasty.
    Schächinger V, Kasper W, Zeiher AM.
    Am J Cardiol; 1996 Jun 01; 77(14):1174-8. PubMed ID: 8651091
    [Abstract] [Full Text] [Related]

  • 2. Adjunctive intracoronary infusion of antithrombin III during percutaneous transluminal coronary angioplasty. Results of a prospective, randomized trial.
    Schächinger V, Allert M, Kasper W, Just H, Vach W, Zeiher AM.
    Circulation; 1994 Nov 01; 90(5):2258-66. PubMed ID: 7955182
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Management and immediate outcome of patients with intracoronary thrombus during percutaneous transluminal coronary angioplasty.
    Vaitkus PT, Herrmann HC, Laskey WK.
    Am Heart J; 1992 Jul 01; 124(1):1-8. PubMed ID: 1615790
    [Abstract] [Full Text] [Related]

  • 7. The intracoronary administration of urokinase following direct PTCA for acute myocardial infarction reduces early restenosis.
    Morishita H, Hattori R, Aoyama T, Kawai C, Yui Y.
    Am Heart J; 1992 May 01; 123(5):1153-6. PubMed ID: 1575126
    [Abstract] [Full Text] [Related]

  • 8. Percutaneous transluminal coronary angioplasty, alone or in combination with urokinase therapy, during acute myocardial infarction.
    Oshima S, Saito T, Nakamura S, Noda K, Date H, Hokimoto S, Taniguchi I, Yamamoto N.
    Jpn Circ J; 1999 Feb 01; 63(2):91-6. PubMed ID: 10084370
    [Abstract] [Full Text] [Related]

  • 9. Prospective, randomized trial of prolonged intracoronary urokinase infusion for chronic total occlusions in native coronary arteries.
    Zidar FJ, Kaplan BM, O'Neill WW, Jones DE, Schreiber TL, Safian RD, Ajluni SC, Sobolski J, Timmis GC, Grines CL.
    J Am Coll Cardiol; 1996 May 01; 27(6):1406-12. PubMed ID: 8626951
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Urokinase infusion after unsuccessful angioplasty in patients with chronic total occlusion of native coronary arteries.
    Ceceña FA.
    Cathet Cardiovasc Diagn; 1993 Mar 01; 28(3):214-8. PubMed ID: 8439996
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Intracoronary dipyridamole reduces the incidence of acute coronary vessel occlusion in percutaneous transluminal coronary angioplasty--a prospective randomized study].
    Heintzen MP, Heidland UE, Klimek WJ, Michel CJ, Kelm M, Leschke M, Schwartzkopff B, Vester EG, Strauer BE.
    Z Kardiol; 1997 Dec 01; 86(12):961-7. PubMed ID: 9499493
    [Abstract] [Full Text] [Related]

  • 16. Site-specific intracoronary thrombolysis with urokinase-coated hydrogel balloons: acute and follow-up studies in 95 patients.
    Glazier JJ, Hirst JA, Kiernan FJ, Fram DB, Eldin AM, Primiano CA, Mitchel JF, McKay RG.
    Cathet Cardiovasc Diagn; 1997 Jul 01; 41(3):246-53. PubMed ID: 9213022
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.